The Scientist - Home

Identifying the mutations that underly unusual sleep traits can provide insights into the biology of sleep and circadian function in humans.

A vaccine successfully induced specific B cells in rhesus macaques, paving the way for an effective HIV vaccine in humans.

Severe cuts to science research funding put graduate students at risk of not finishing their degrees. The American Chemical Society launched a grant to support students in crisis. 

Thought too hard to do, a new platform evolved proteins in mammalian cells, which could help researchers design drugs that work better in humans. 

With complicated lifecycles and genetics, parasitic worms can be hard to study, but organoids unveil new insight into their biology and a path to better drugs.

Gut bacteria bioaccumulated so-called forever chemicals, leading to new insights on how PFAS affects biology and paths to bioremediation.

The academic system prioritizes publications and grants over real-world impact; researchers now advocate for a shift to value collaboration and translational discoveries.

Triple-negative breast cancer cells build bridges to activate adipocytes and fuel themselves, highlighting a target for future therapies.

How can neurons respond to optical stimulation without genetic or structural alterations? Turns out that a thin-layer carbon sheet might do the trick.

Sugars, amino acids, and fatty acids activate distinct subsets of intestinal neurons, revealing how the gut responds to different food components.

Organoids generated from tonsils removed during surgeries provide a reliable in vitro platform to study human immune responses.

Some lipids may protect against excessive daytime sleepiness, a metabolomics study that involved thousands of people around the world suggests.